Multiple Myeloma

Saturday, May 5, 2018 from 12:45 PM to 2:15 PM
Available for up to 1.50 hours of CPE credit
Activity Number: 0217-9999-18-087-L01-P

Monique D. Giordana, Pharm.D., BCOP

  • Faculty: Monique D. Giordana, Pharm.D., BCOP
    Hematology/Oncology Clinical Pharmacy Specialist, Regions Hospital, Saint Paul, Minnesota
      View Biography

Learning Objectives
1. Design an appropriate patient‐specific treatment, supportive care, and monitoring plan taking into consideration efficacy and safety outcomes from clinical trials and current treatment guidelines for patients with multiple myeloma.
2. Evaluate oncology pharmacy services for compliance with established REMS regulations and standards.
3. Devise and communicate appropriate plans for preventing, monitoring, and managing common problems associated with the treatment of cancers, including bone metastases in multiple myeloma patients and thromboembolism, hypercalcemia of malignancy, and spinal cord compression in all oncology patients.
© 2019 American College of Clinical Pharmacy and American Society of Health‑System Pharmacists